Raras
Buscar doenças, sintomas, genes...
Síndrome de surdez-linfedema-leucemia
ORPHA:3226CID-10 · D46.7CID-11 · BD93.0OMIM 614038DOENÇA RARA
Sangue / imune
Sinônimos clínicos: Síndrome de perda auditiva-linfedema-leucemia · Síndrome Emberger

A síndrome de Surdez - linfedema - leucemia é uma doença genética muito rara e grave, que se manifesta com inchaço (linfedema) primário, problemas no sistema de defesa do corpo (imunodeficiência) e distúrbios relacionados ao sangue.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

A síndrome de Surdez - linfedema - leucemia é uma doença genética muito rara e grave, que se manifesta com inchaço (linfedema) primário, problemas no sistema de defesa do corpo (imunodeficiência) e distúrbios relacionados ao sangue.

🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: D46.7
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🦴
Ossos e articulações
3 sintomas
🩸
Sangue
2 sintomas
😀
Face
1 sintomas

+ 8 sintomas em outras categorias

Características mais comuns

93%prev.
Linfedema
Frequência: 13/14
50%prev.
Mielodisplasia
Frequência: 7/14
43%prev.
Leucemia mieloide aguda
Frequência: 6/14
29%prev.
Razão CD4:CD8 invertida
Frequência: 4/14
29%prev.
Verrugas
Frequência: 4/14
17%prev.
Pescoço alado
Ocasional (29-5%)
14sintomas
Muito frequente (1)
Frequente (2)
Ocasional (7)
Sem dados (4)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 14 características clínicas mais associadas, ordenadas por frequência.

LinfedemaLymphedema
Frequência: 13/1493%
MielodisplasiaMyelodysplasia
Frequência: 7/1450%
Leucemia mieloide agudaAcute myeloid leukemia
Frequência: 6/1443%
Razão CD4:CD8 invertidaInverted CD4:CD8 ratio
Frequência: 4/1429%
VerrugasVerrucae
Frequência: 4/1429%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa6
Últimos 10 anos200publicações
Pico202539 papers
Linha do tempo
20202020Hoje · 2026🧪 2017Primeiro ensaio clínico📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

1 gene identificado com associação a esta condição.

Curadoria gene-doença

fontes oficiais
GATA2
GATA2Endothelial transcription factor GATA-2Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Transcriptional activator which regulates endothelin-1 gene expression in endothelial cells. Binds to the consensus sequence 5'-AGATAG-3'

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (3)
RUNX1 regulates transcription of genes involved in differentiation of HSCsTranscriptional regulation of granulopoiesisFactors involved in megakaryocyte development and platelet production
MECANISMO DE DOENÇA

Immunodeficiency 21

An immunodeficiency disease characterized by profoundly decreased or absent monocytes, B-lymphocytes, natural killer lymphocytes, and circulating and tissue dendritic cells, with little or no effect on T-cell numbers. Clinical features of DCML include susceptibility to disseminated non-tuberculous mycobacterial infections, papillomavirus infections, opportunistic fungal infections, and pulmonary alveolar proteinosis. Bone marrow hypocellularity and dysplasia of myeloid, erythroid, and megakaryocytic lineages are present in most patients, as are karyotypic abnormalities, including monosomy 7 and trisomy 8. This syndrome links susceptibility to mycobacterial, viral, and fungal infections with malignancy and can be transmitted in an autosomal dominant pattern.

EXPRESSÃO TECIDUAL(Ubíquo)
Útero
86.1 TPM
Próstata
69.7 TPM
Cervix Endocervix
65.8 TPM
Cervix Ectocervix
62.1 TPM
Fallopian Tube
57.5 TPM
OUTRAS DOENÇAS (4)
deafness-lymphedema-leukemia syndromemonocytopenia with susceptibility to infectionsacute myeloid leukemiamyelodysplastic syndrome
HGNC:4171UniProt:P23769

Variantes genéticas (ClinVar)

391 variantes patogênicas registradas no ClinVar.

🧬 GATA2: NM_032638.5(GATA2):c.112C>T (p.Gln38Ter) ()
🧬 GATA2: NM_032638.5(GATA2):c.20_41del (p.Gln7fs) ()
🧬 GATA2: NM_032638.5(GATA2):c.786_787insCGTGG (p.Gly263fs) ()
🧬 GATA2: NM_032638.5(GATA2):c.1085_1092dup (p.Asn365fs) ()
🧬 GATA2: NM_032638.5(GATA2):c.308_318del (p.Ala103fs) ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 1,508 variantes classificadas pelo ClinVar.

75
679
754
Patogênica (5.0%)
VUS (45.0%)
Benigna (50.0%)
VARIANTES MAIS SIGNIFICATIVAS
GATA2: NM_032638.5(GATA2):c.112C>T (p.Gln38Ter) [Pathogenic]
GATA2: NM_032638.5(GATA2):c.230-3C>A [Uncertain significance]
GATA2: NM_032638.5(GATA2):c.125C>A (p.Pro42Gln) [Uncertain significance]
GATA2: NM_032638.5(GATA2):c.265T>G (p.Leu89Val) [Uncertain significance]
GATA2: NM_032638.5(GATA2):c.634A>G (p.Lys212Glu) [Uncertain significance]

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Síndrome de surdez-linfedema-leucemia

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
0 papers (10 anos)
#1

GATA2 deficiency exacerbates chronic liver injury via disrupting hepatocyte death-regeneration balance: Clinical, histopathological, and molecular evidence.

World journal of stem cells2026 Feb 26

GATA-binding protein 2 (GATA2) is a critical transcription factor that plays an essential role in maintaining the stemness of hematopoietic stem cells. Mutations in GATA2 are recognized as disease-causing mutations for aplastic anemia (AA) and myelodysplastic syndromes; however, the mechanisms linking these mutations to chronic liver injury (CLI) (e.g., cirrhosis) remain elusive. To investigate the molecular mechanisms through which GATA2 deficiency promotes CLI. Whole genome sequencing was performed to identify loss-of-function mutations in GATA2 in a 55-year-old female patient who was suspected of and later diagnosed with AA and developed cirrhosis one year post-diagnosis. After establishing the genetic association between GATA2 mutations and cirrhosis through clinical case analysis, liver injury murine and hepatocyte models were developed to characterize GATA2 expression in response to liver injury. rAAV8-TBG-Gata2-shRNA-mediated liver-specific Gata2 knockdown was employed to elucidate the role of GATA2 in exacerbating liver injury. The patient presented with a three-year medical history of dizziness, fatigue, and thrombocytopenia. Following conventional treatment, she developed severe fatigue, abdominal distension, and jaundice, indicative of liver disease. Multimodal evaluations, including bone marrow biopsy, flow cytometry, liver biopsy, and genetic testing, confirmed GATA2 mutation-associated AA complicated by cirrhosis. Experimental studies in cellular and animal models demonstrated compensatory upregulation of hepatocyte GATA2 in response to endoplasmic reticulum stress and oxidative stress. Mechanistically, liver-specific Gata2 knockdown exacerbated hepatocyte apoptosis, necroptosis, ferroptosis, and impaired regeneration. Furthermore, Gata2 knockdown suppressed the adaptive unfolded protein response, attenuated the antioxidant response, and inhibited fatty acid β-oxidation. GATA2 deficiency drives the CLI by disrupting the hepatocyte death-regeneration balance.

#2

IL-1β as Target to Induce Synthetic Lethality in KRAS Mutant Biliary Tract Cancer.

Clinical and molecular hepatology2026 Feb 20

Biliary tract cancer (BTC) frequently harbors KRAS mutations, which are associated with resistance to traditional treatment and a poor prognosis. Synthetic lethality (SL) strategy may provide other targets of KRAS. Therefore, we aim to identify and validate potential therapeutic target of KRAS for the treatment of BTC via SL. The dependency (DepMap) projects were used to predict the synthetic lethal gene of KRAS. FDA-approved anticancer drug library was applied to screen potential drugs effective against KRAS-mutant BTC. Furthermore, the synthetic lethal effects or corresponding mechanisms of potential genes and drugs on BTC was investigated using KRAS-mutant and KRAS-wild type BTC cell lines, patient-derived xenografts (PDX), KRAS oncogene-driven tumor models, as well as other KRAS-mutant cancer cell lines. Initially, we discovered that the loss of GATA2 reduced the viability of KRAS-mutant but not KRAS-wild-type BTC. Subsequently, the drug library screened out disulfiram, which primarily exerts a synthetic lethal effect by inhibiting IL-1β in KRAS-mutant BTC. Mechanistically, GATA2 specifically enhanced the transcription of IL-1β to promote NF-κB signaling in KRAS-mutant BTC. IL-1β inhibition phenocopied GATA2 deficiency, leading to reduced KRAS-mutant BTC viability. These synthetically lethal effects were confirmed using PDX, a KRAS oncogene-driven tumor model, as well as in other KRAS-mutant cancer cell lines. In summary, these results indicate that inhibiting GATA2/IL1β could be a therapeutic strategy in KRAS-mutant BTC and potentially other cancers.

#3

Clinical relevance of mosaic variants detected by exome sequencing.

The Journal of allergy and clinical immunology2026 Feb 20

Mosaic variants represent a significant but underrecognized contributor to human disease such as cancer and immune diseases. Despite advances in genetic diagnostics, mosaic variant detection remains challenging as a result of low variant allele fractions, tissue specificity, and clinical heterogeneity. We investigated the prevalence, diagnostic impact, and clinical relevance of mosaic variants in participants with immune disorders. Exome sequencing of blood and/or saliva was performed in 2655 participants, including 2064 affected participants. Mosaic variants were detected using two algorithms, LoFreq2 and Mutect2. A subset of the detected variants was orthogonally validated. Clinical data were retrospectively analyzed to assess the clinical significance of these variants. Mosaic variants associated with immune disorders contributed to a molecular diagnosis in 29 (1.4%) of 2064 affected participants. Notably, 10 (34%) of 29 of diagnostic variants were missed by standard germline analysis as a result of low variant allele fractions. Clinically relevant parental mosaicism was ascertained in two families. Enrichment of mosaic variants was observed in clonal hematopoiesis-related genes driven by older age and GATA2 deficiency, with prognostic implications for hematologic disorders. Finally, chemotherapy drug resistance variants in NRAS, KRAS, and IDH2 were identified, demonstrating the potential for mosaic variant detection to inform treatment strategies. Mosaic variants contribute significantly to the molecular diagnosis and prognosis of immune and hematologic disorders and are missed by typical germline variant-calling workflow.

#4

GATA2 controls alveolar macrophage inflammatory gene expression and metabolic function.

JCI insight2026 Feb 19

Alveolar macrophages (AMs) catabolize lipid-rich pulmonary surfactant to support gas exchange and have anti-inflammatory programming to limit tissue damage in response to minor challenges. GATA transcription factors (TFs) shape immune cell fates and GATA2 is expressed in a lung-specific manner in macrophages. GATA2 mutations and lung macrophage downregulation of GATA2 have been associated with chronic pulmonary pathologies in humans, but the role of GATA2 in coordinating AM function is not well defined. Using mice with myeloid-specific deletion of the GATA2 DNA binding C-terminal zinc finger domain, we show that GATA2 deficiency promotes enhanced inflammatory gene expression and metabolic dysfunction in AMs in response to type 2 stimuli. While homeostatic functions of AMs remain largely intact, GATA2 deficiency increases expression of type 2 response genes during IL-33-induced inflammation. Coincident with GATA2-dependent expression of genes in metabolic pathways, seahorse metabolic flux analysis indicates that AM metabolism is compromised in the absence of GATA2. AM GATA2-dependent gene networks are enriched for targets of TFs previously demonstrated to interact with GATA2 in other cellular contexts, including PU.1, PPARγ, and other regulators of AM function. Our data suggest that GATA2 modulates AM metabolic and transcriptomic programming to restrain responses and maintain AM identity during inflammation.

#5

A CRISPR-Based Humanized Model Reveals Cooperative Role of STAG2 Loss in Familial GATA2-Deficient MDS Progression.

bioRxiv : the preprint server for biology2026 Feb 02

Myelodysplastic syndrome (MDS) is a heterogeneous myeloid malignancy driven by hematopoietic stem cell dysfunction, leading to ineffective hematopoiesis and cytopenias. Familial GATA2 deficiency is the most common cause of Myelodysplastic syndrome in adolescents, with progression often accelerated by co-occurring mutations, notably STAG2 loss-of-function. Using CRISPR/Cas9-mediated genome engineering in primary human fetal liver-derived hematopoietic stem cells and xenotransplantation in mice, we modeled GATA2-deficient Myelodysplastic syndrome with acquired STAG2 loss to investigate disease initiation and progression. While GATA2 deficiency alone had minimal short-term impact in our model, combined GATA2 and STAG2 loss increased hematopoietic stem cell maintenance and self-renewal, induced a myeloid-lineage bias, and expanded primitive progenitors. Single-cell transcriptional profiling revealed upregulation of stemness genes and inflammatory pathways. This humanized model faithfully recapitulates high-risk GATA2-deficient Myelodysplastic syndrome, providing mechanistic insight into how cooperative mutations drive stem cell expansion, inflammatory signaling, and myeloid skewing.

Publicações recentes

Ver todas no PubMed

📚 EuropePMCmostrando 198

2026

GATA2 Deficiency Syndrome: A Case Series and Literature Review.

Journal of clinical immunology
2026

GATA2 deficiency exacerbates chronic liver injury via disrupting hepatocyte death-regeneration balance: Clinical, histopathological, and molecular evidence.

World journal of stem cells
2026

Clinical relevance of mosaic variants detected by exome sequencing.

The Journal of allergy and clinical immunology
2026

IL-1β as Target to Induce Synthetic Lethality in KRAS Mutant Biliary Tract Cancer.

Clinical and molecular hepatology
2026

GATA2 controls alveolar macrophage inflammatory gene expression and metabolic function.

JCI insight
2026

A CRISPR-Based Humanized Model Reveals Cooperative Role of STAG2 Loss in Familial GATA2-Deficient MDS Progression.

bioRxiv : the preprint server for biology
2026

GATA2 at 14: genotype-phenotype correlations.

Haematologica
2025

Functional Properties of POU1F1 Mutants in the Transcriptional Regulation of the Thyrotropin β Gene Compared with the Prolactin Gene.

International journal of molecular sciences
2025

GATA2 deficiency presenting with Hodgkin's lymphoma and cryptogenic organizing pneumonia: a case report of two siblings.

Frontiers in medicine
2025

Crucial roles of mesenchymal Gata2 in murine epididymal development.

Proceedings of the National Academy of Sciences of the United States of America
2025

Bone marrow transplantation of a GATA-2 patient with an active non-tuberculous mycobacterial infection.

BMJ case reports
2025

[A case of pulmonary alveolar proteinosis secondary to GATA2 deficiency combined with splenic M. kansasii infection and literature review].

Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases
2025

Multi-omics elucidation of KDM5C, KDM6A, and KMT2B roles in cancer epigenetic dysregulation and transcriptional reprogramming.

Communications biology
2025

GATA2 deficiency in an adult with alveolar proteinosis, infections, lymphadenopathy with granulomatosis, and immune deficiency: case report.

Frontiers in immunology
2025

Human iPSCs-based modeling unveils SETBP1 as a driver of chromatin rewiring in GATA2 deficiency.

Nature communications
2025

Non-Malignant Granulocyte and Monocyte Disorders: An Update.

British journal of biomedical science
2025

Pediatric MDS in GATA2 deficiency, narrowing the scope.

Blood cancer journal
2025

Pediatric Acute Megakaryoblastic Leukemia with a GATA2 Mutation and Monosomy 7: A Case Report and Clinical Management Challenges.

Reports (MDPI)
2025

Disseminated mycobacterium kansasii infection revealing GATA2 haploinsufficiency after presumed tuberculosis and early lung cancer.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
2025

CRISPR-engineered human GATA2 deficiency model uncovers mitotic dysfunction and premature aging in HSPCs, impairing hematopoietic fitness.

Leukemia
2025

A Case Report of Systemic Lupus Erythematosus in GATA2 Deficiency: Expanding the Spectrum of Rheumatological Features.

International journal of rheumatic diseases
2025

Case Report: GATA2 deficiency in two families with novel frameshift variants highlighting phenotypic diversity and need for early diagnosis.

Frontiers in immunology
2025

Immune deficiency due to SARS-CoV-2 infection in a child with GATA2-mutated AML: A case report.

Medicine
2025

Impaired DNA damage responses and inflammatory signaling underpin hematopoietic stem cell defects in Gata2 haploinsufficiency.

Stem cell reports
2025

GATA2 Deficiency in an Adolescent With Disseminated Herpes Simplex Virus Hemophagocytic Lymphohistiocytosis.

Journal of pediatric hematology/oncology
2025

Treatment of GATA2 deficiency by allele-specific CRISPR-Cas9-directed gene correction in hematopoietic stem cells.

Molecular therapy : the journal of the American Society of Gene Therapy
2026

Further Personalizing Medicine in Immune Disorders: Genomic Findings and Hematopoietic Cell Transplantation Survival.

Transplantation
2025

Age-dependent phenotypic and molecular evolution of pediatric MDS arising from GATA2 deficiency.

Blood cancer journal
2025

Sustained Remission of Refractory EBV-Associated CNS Post-Transplant Lymphoproliferative Disorder After Cord Blood Transplantation Using Donor-Derived CD19/CD20 Bispecific CAR-T Cells in a Pediatric Patient With GATA2 Deficiency.

Pediatric blood & cancer
2025

Germline and somatic genetic landscape of pediatric myelodysplastic syndromes.

Haematologica
2025

Growth hormone regulates deiodinase type 2 and 3 expression via GATA.

Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society
2025

CT features of genetic mutation-related pulmonary alveolar proteinosis (CCR2 and GATA2 deficiency).

Diagnostic and interventional imaging
2025

Diffuse molluscum contagiosum associated with GATA2 deficiency.

Annales de dermatologie et de venereologie
2025

GATA2 Deficiency With Early-Onset and Progressive Interstitial Lung Disease.

Respirology case reports
2025

Case Report: Hydroa vacciniforme-like lymphoproliferative disorder, an EBV-associated disease, successfully treated with hematopoietic stem cell transplantation.

Frontiers in immunology
2025

DOCK2 Deficiency and GATA2 Haploinsufficiency Can Underlie Critical Coronavirus Disease 2019 (COVID-19) Pneumonia.

Journal of clinical immunology
2025

Hematological phenotypes in GATA2 deficiency syndrome arise from aging, maladaptation to proliferation, and somatic events.

Blood advances
2025

Aggressive Head and Neck Squamous Cell Carcinoma in the Setting of GATA2 Deficiency.

Head & neck
2025

Bone Marrow CD8 + Abundance Inversely Correlates with Progressive Marrow Fibrosis and Myelodysplastic Evolution in GATA2 Deficiency: Case Report.

Journal of clinical immunology
2025

Multiple phenotypes and epigenetic profiles in a three-generation family history with GATA2 deficiency.

Leukemia
2025

GATA2 mutated allele specific expression is associated with a hyporesponsive state of HSC in GATA2 deficiency syndrome.

Blood cancer journal
2025

Modeling GATA2 deficiency in mice: the R396Q mutation disrupts normal hematopoiesis.

Leukemia
2024

GATA2 participates in protection against hypoxia-induced pulmonary vascular remodeling.

PloS one
2024

Rare Case of Germline GATA2-Deficiency With Merkel Cell Carcinoma and Acute Myeloid Leukemia.

Cancer reports (Hoboken, N.J.)
2024

GSDMD Mediates Ang II-Induced Hypertensive Nephropathy by Regulating the GATA2/AQP4 Signaling Pathway.

Journal of inflammation research
2025

Genome-first determination of the prevalence and penetrance of eight germline myeloid malignancy predisposition genes: a study of two population-based cohorts.

Leukemia
2024

GATA2 deficiency and hemophagocytic lymphohistiocytosis (HLH): a systematic review of reported cases.

BMC infectious diseases
2024

Genetic predisposition to myelodysplastic syndrome: Genetic counseling and transplant implications.

Seminars in hematology
2025

Inherited Predispositions to Myeloid Neoplasms: Pathogenesis and Clinical Implications.

Annual review of pathology
2024

BAFF-associated granulomatous lung disease in a patient with GATA2 deficiency.

The journal of allergy and clinical immunology. Global
2024

High frequency of GATA2 variants in patients with pulmonary fungal disease without immunocompromised risk factors: a retrospective study.

Journal of thoracic disease
2024

Human papillomavirus disease in GATA2 deficiency: a genetic predisposition to HPV-associated female anogenital malignancy.

Frontiers in immunology
2024

Renegotiation, uncertainty, imagination: Assemblage perspectives on reproductive and family planning with an Inborn Error of immunity.

Social science & medicine (1982)
2024

Evaluation of recurrent and recalcitrant warts in a deaf adolescent male reveals GATA2 deficiency.

The journal of allergy and clinical immunology. Global
2024

CEBPA and GATA2 mutation and a transient blood group discrepancy in a patient with acute myeloid leukaemia.

Transfusion medicine (Oxford, England)
2026

Long-term outcome after allogeneic stem cell transplantation for GATA2 deficiency: An analysis of 67 adults and children from France and Belgium.

British journal of haematology
2024

Prognostic significance of GATA2 in patients with MDS/AML: a systematic review and meta-analysis.

Annals of hematology
2024

Nudt15-mediated inflammatory signaling contributes to divergent outcomes in leukemogenesis and hematopoiesis.

Leukemia
2024

The different faces of GATA2 deficiency: implications for therapy and surveillance.

Frontiers in oncology
2024

GATA2 deficiency syndrome: A compensatory mechanism gone awry?

British journal of haematology
2024

[Allogeneic hematopoietic stem cell transplantation in a patient with MonoMAC syndrome and hematopoietic dysplasia which was induced by GATA2 deficiency: a case report and literature review].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
2024

GATA2 heterozygosity causes an epigenetic feedback mechanism resulting in myeloid and erythroid dysplasia.

British journal of haematology
2024

Haemophagocytic lymphohistiocytosis caused by GATA2 deficiency: a report on three patients.

BMC infectious diseases
2024

Discerning clinicopathological features of congenital neutropenia syndromes: an approach to diagnostically challenging differential diagnoses.

Journal of clinical pathology
2024

Somatic mutations in four novel genes contribute to homologous recombination deficiency in breast cancer: a real-world clinical tumor sequencing study.

The journal of pathology. Clinical research
2024

Malignant progression of preleukemic disorders.

Blood
2024

Pathogenic GATA2 genetic variants utilize an obligate enhancer mechanism to distort a multilineage differentiation program.

Proceedings of the National Academy of Sciences of the United States of America
2025

Susceptibility to mycobacterial infection in VEXAS syndrome.

Rheumatology (Oxford, England)
2024

GATA2 deficiency of a novel missense variant with multiorgan inflammation.

Rheumatology (Oxford, England)
2024

Perturbed collagen metabolism underlies lymphatic recanalization failure in Gata2 heterozygous deficient mice.

Journal of biochemistry
2023

Genetic Characteristics of Patients with Young-Onset Myelodysplastic Neoplasms.

Journal of clinical medicine
2023

Mechanisms of resistance to hypomethylating agents and BCL-2 inhibitors.

Best practice & research. Clinical haematology
2023

Development of MDS in Pediatric Patients with GATA2 Deficiency: Increased Histone Trimethylation and Deregulated Apoptosis as Potential Drivers of Transformation.

Cancers
2023

The role of GATA2 in adult hematopoiesis and cell fate determination.

Frontiers in cell and developmental biology
2023

Profound and selective lymphopaenia in primary lymphatic anomaly patients demonstrates the significance of lymphatic-lymphocyte interactions.

Frontiers in immunology
2023

Cytogenetics in the management of bone marrow failure syndromes: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).

Current research in translational medicine
2023

Visceral Leishmaniasis Revealing Undiagnosed Inborn Errors of Immunity.

Revista da Sociedade Brasileira de Medicina Tropical
2023

Gata2 noncoding genetic variation as a determinant of hematopoietic stem/progenitor cell mobilization efficiency.

Blood advances
2023

A Nationwide Study of GATA2 Deficiency in Italy Reveals Novel Symptoms and Genotype-phenotype Association.

Journal of clinical immunology
2024

GATA2 deficiency in a patient with a somatic mutation of GATA2.

QJM : monthly journal of the Association of Physicians
2023

Extensive dental caries and periodontal disease in a child with GATA2 deficiency.

Journal of clinical and experimental dentistry
2023

Disseminated Nontuberculous Mycobacterial Infection in a Tertiary Referral Hospital in South Korea: A Retrospective Observational Study.

Yonsei medical journal
2023

Case Report: Missing zinc finger domains: hemophagocytic lymphohistiocytosis in a GATA2 deficiency patient triggered by non-tuberculous mycobacteriosis.

Frontiers in immunology
2024

Recalcitrant multiple warts in GATA2 deficiency treated with systemic etretinate.

The Journal of dermatology
2023

The Molecular and Genetic Mechanisms of Inherited Bone Marrow Failure Syndromes: The Role of Inflammatory Cytokines in Their Pathogenesis.

Biomolecules
2023

A novel GATA2 distal enhancer mutation results in MonoMAC syndrome in 2 second cousins.

Blood advances
2023

Invasive mucorales sinusitis in a young patient with Emberger syndrome and newly diagnosed AML: A case report and literature review of invasive fungal infections in GATA2 deficiency.

Mycoses
2023

Inherited bone marrow failure syndromes and germline predisposition to myeloid neoplasia: A practical approach for the pathologist.

Seminars in diagnostic pathology
2023

Prevalence and significance of DDX41 gene variants in the general population.

Blood
2023

Atypical Cutaneous Viral Infections Reveal an Inborn Error of Immunity in 8 Patients.

Microorganisms
2023

Lineage skewing and genome instability underlie marrow failure in a zebrafish model of GATA2 deficiency.

Cell reports
2023

Interferon regulatory factor-8-dependent innate immune alarm senses GATA2 deficiency to alter hematopoietic differentiation and function.

Current opinion in hematology
2023

GATA2 Deficiency: Predisposition to Myeloid Malignancy and Hematopoietic Cell Transplantation.

Current hematologic malignancy reports
2023

Prevalence and clinical expression of germ line predisposition to myeloid neoplasms in adults with marrow hypocellularity.

Blood
2023

Successful allogeneic hematopoietic stem cell transplantation for myelodysplastic neoplasms complicated with secondary pulmonary alveolar proteinosis and Behçet's disease harboring GATA2 mutation.

International journal of hematology
2023

Infection and myelodysplasia: A case report of GATA2 deficiency in a South African patient.

Clinical case reports
2023

TP53 Mutations Are Associated with Increased Infections and Reduced Hematopoietic Cell Transplantation Rates in Myelodysplastic Syndrome and Acute Myeloid Leukemia.

Transplantation and cellular therapy
2023

The Clinical Spectrum, Diagnosis, and Management of GATA2 Deficiency.

Cancers
2023

Epigenome profiling reveals aberrant DNA methylation signature in GATA2 deficiency.

Haematologica
2023

Pathogenic human variant that dislocates GATA2 zinc fingers disrupts hematopoietic gene expression and signaling networks.

The Journal of clinical investigation
2023

Applicability of T cell receptor repertoire sequencing analysis to unbalanced clinical samples - comparing the T cell receptor repertoire of GATA2 deficient patients and healthy controls.

Swiss medical weekly
2023

Introduction to a review series on germ line predisposition to hematologic malignancies: time to consider germ line testing.

Blood
2023

[Nontuberculous mycobacteria infection and pulmonary alveolar proteinosis in a patient with hematopoietic defects].

Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases
2023

Somatic genetic alterations predict hematological progression in GATA2 deficiency.

Haematologica
2022

GATA2 deficiency detected by newborn screening for SCID: A case report.

Frontiers in pediatrics
2023

Gata2-regulated Gfi1b expression controls endothelial programming during endothelial-to-hematopoietic transition.

Blood advances
2023

Cellular and metabolic characteristics of pre-leukemic hematopoietic progenitors with GATA2 haploinsufficiency.

Haematologica
2023

The spectrum of GATA2 deficiency syndrome.

Blood
2023

Clinical, Imaging, and Laboratory Findings in Patients With GATA2 Deficiency Presenting With Early-Onset Ischemic Stroke.

Neurology
2022

GATA2 haploinsufficient patients lack innate lymphoid cells that arise after hematopoietic cell transplantation.

Frontiers in immunology
2022

MonoMAC syndrome with GATA2 novel mutation: A case report.

Leukemia research reports
2023

Decreasing GDF15 Promotes Inflammatory Signals and Neutrophil Infiltration in Psoriasis Models.

The Journal of investigative dermatology
2022

Impaired Interleukin-15 Signaling via BMPR2 Loss Drives Natural Killer Cell Deficiency and Pulmonary Hypertension.

Hypertension (Dallas, Tex. : 1979)
2022

[GATA2 gene mutations: 3 cases].

La Revue de medecine interne
2022

Case report: Successful allogeneic stem cell transplantation in a child with novel GATA2 defect associated B-cell acute lymphoblastic leukemia.

Frontiers in immunology
2022

Inflammatory diseases in hematology: a review.

American journal of physiology. Cell physiology
2022

Facial lymphoedema, viral warts, and myelodysplastic syndrome: the protean condition of GATA2 deficiency.

Lancet (London, England)
2022

GATA 2 Deficiency: Focus on Immune System Impairment.

Frontiers in immunology
2022

GATA2 deficiency and MDS/AML: Experimental strategies for disease modelling and future therapeutic prospects.

British journal of haematology
2022

Utility of targeted next generation sequencing for inborn errors of immunity at a tertiary care centre in North India.

Scientific reports
2022

GATA2 deficiency associated with copy number variation: A reference for considering inborn errors of immunity.

The journal of allergy and clinical immunology. In practice
2022

Pulmonary Alveolar Proteinosis due to Familial Myelodysplastic Syndrome with resolution after stem cell transplant.

Autopsy & case reports
2022

GATA2 Deficiency in Adult Life Is Characterized by Phenotypic Diversity and Delayed Diagnosis.

Frontiers in immunology
2022

Heterozygous variants in GATA2 contribute to DCML deficiency in mice by disrupting tandem protein binding.

Communications biology
2022

Single Center Experience With Pediatric Patients With GATA2 Deficiency.

Frontiers in pediatrics
2022

Morbidity, Mortality, and Therapeutics in Combined Immunodeficiency: Data From the USIDNET Registry.

The journal of allergy and clinical immunology. In practice
2022

Renal Klotho and inorganic phosphate are extrinsic factors that antagonistically regulate hematopoietic stem cell maintenance.

Cell reports
2022

GATA2 deficiency elevates interferon regulatory factor-8 to subvert a progenitor cell differentiation program.

Blood advances
2023

Redefining WILD syndrome: a primary lymphatic dysplasia with congenital multisegmental lymphoedema, cutaneous lymphovascular malformation, CD4 lymphopaenia and warts.

Journal of medical genetics
2022

A Nationwide Study of GATA2 Deficiency in Norway-the Majority of Patients Have Undergone Allo-HSCT.

Journal of clinical immunology
2022

Majocchi's granuloma in a patient with GATA2 haploinsufficiency undergoing hematopoietic stem cell transplantation.

Transplant infectious disease : an official journal of the Transplantation Society
2022

Survey of germline variants in cancer-associated genes in young adults with colorectal cancer.

Genes, chromosomes & cancer
2021

Combined Mutation of the GATA2 Gene and STAT5B Gene in a Patient with Hypogammaglobulinemia and Autoimmunity.

The Tohoku journal of experimental medicine
2021

Deficiencies in the DNA Binding Protein ARID3a Alter Chromatin Structures Important for Early Human Erythropoiesis.

ImmunoHorizons
2021

GATA2 deficiency phenotype associated with tandem duplication of GATA2 and overexpression of GATA2-AS1.

Blood advances
2021

A 30-Year-Old Immune Deficient Woman With Persistent Cough and Shortness of Breath.

Chest
2021

Differential Requirement of Gata2a and Gata2b for Primitive and Definitive Myeloid Development in Zebrafish.

Frontiers in cell and developmental biology
2022

Finding the best haematopoietic stem cell transplant regimen for GATA2 haploinsufficiency: how close are we?

British journal of haematology
2022

Donor source and post-transplantation cyclophosphamide influence outcome in allogeneic stem cell transplantation for GATA2 deficiency.

British journal of haematology
2022

ASXL1 and STAG2 are common mutations in GATA2 deficiency patients with bone marrow disease and myelodysplastic syndrome.

Blood advances
2021

CISH attenuates homeostatic cytokine signaling to promote lung-specific macrophage programming and function.

Science signaling
2022

Gata2 +9.5 enhancer regulates adult hematopoietic stem cell self-renewal and T-cell development.

Blood advances
2021

Gata2 haploinsufficiency promotes proliferation and functional decline of hematopoietic stem cells with myeloid bias during aging.

Blood advances
2021

Association of unbalanced translocation der(1;7) with germline GATA2 mutations.

Blood
2021

Generalized verrucosis in GATA2 deficiency successfully treated with systemic acitretin and trichloroacetic acid.

Pediatric dermatology
2021

GATA2 and marrow failure.

Best practice & research. Clinical haematology
2021

GATA2 deficiency syndrome: A decade of discovery.

Human mutation
2021

Chronic Kidney Disease Induced by Cisplatin, Folic Acid and Renal Ischemia Reperfusion Induces Anemia and Promotes GATA-2 Activation in Mice.

Biomedicines
2021

Mycobacterial diseases in patients with inborn errors of immunity.

Current opinion in immunology
2021

Generation of two heterozygous GATA2 CRISPR/Cas9-edited iPSC lines, R398W and R396Q, for modeling GATA2 deficiency.

Stem cell research
2021

"Oral Manifestations of Patients with Inherited Defect in Phagocyte Number or Function" a systematic review.

Clinical immunology (Orlando, Fla.)
2022

miR-181c regulates MCL1 and cell survival in GATA2 deficient cells.

Journal of leukocyte biology
2021

Hematopoietic stem cell transplantation in children and adolescents with GATA2-related myelodysplastic syndrome.

Bone marrow transplantation
2022

Germline GATA2 variant disrupting endothelial eNOS function and angiogenesis can be restored by c-Jun/AP-1 upregulation.

Haematologica
2020

Fertility preservation before hematopoetic stem cell transplantation: a case series of women with GATA binding protein 2 deficiency, dedicator of cytokinesis 8 deficiency, and sickle cell disease.

F&S reports
2021

Single-cell ATAC-seq reveals GATA2-dependent priming defect in myeloid and a maturation bottleneck in lymphoid lineages.

Blood advances
2021

Recalcitrant warts and lymphopenia in a young male.

JAAD case reports
2021

Pulmonary Manifestations of GATA2 Deficiency.

Chest
2021

Disseminated nontuberculous mycobacteriosis and fungemia after second delivery in a patient with MonoMAC syndrome/GATA2 mutation: a case report.

BMC infectious diseases
2021

Hematopoietic Cell Transplantation and Outcomes Related to Human Papillomavirus Disease in GATA2 Deficiency.

Transplantation and cellular therapy
2021

High penetrance of myeloid neoplasia with diverse clinical and cytogenetic features in three siblings with a familial GATA2 deficiency.

Cancer genetics
2021

A novel germline GATA2 frameshift mutation with a premature stop codon in a family with congenital sensory hearing loss and myelodysplastic syndrome.

International journal of hematology
2021

When to suspect GATA2 deficiency in pediatric patients: from complete blood count to diagnosis.

Pediatric hematology and oncology
2021

Alveolar Proteinosis, Infectious Complications and Monocytopenia Associated with GATA2 Deficiency.

Neuro endocrinology letters
2021

Diagnosis of GATA2 Deficiency in a Young Woman with Hemophagocytic Lymphohistiocytosis Triggered by Acute Systemic Cytomegalovirus Infection.

The American journal of case reports
2021

Somatic GATA2 mutations define a subgroup of myeloid malignancy patients at high risk for invasive fungal disease.

Blood advances
2020

Deficiency of Rbpj Leads to Defective Stress-Induced Hematopoietic Stem Cell Functions and Hif Mediated Activation of Non-canonical Notch Signaling Pathways.

Frontiers in cell and developmental biology
2020

Effect of the unfolded protein response and oxidative stress on mutagenesis in CSF3R: a model for evolution of severe congenital neutropenia to myelodysplastic syndrome/acute myeloid leukemia.

Mutagenesis
2021

Poly(ADP-ribose) polymerase inhibitor-associated myelodysplastic syndrome/acute myeloid leukemia: a pharmacovigilance analysis of the FAERS database.

ESMO open
2021

Inherited GATA2 Deficiency Is Dominant by Haploinsufficiency and Displays Incomplete Clinical Penetrance.

Journal of clinical immunology
2021

GATA2 mutation with recurrent haemophagocytic lymphohistiocytosis and panniculitis: a case report.

Rheumatology (Oxford, England)
2020

Severe influenza in a paediatric patient with GATA2 deficiency and Emberger syndrome.

BMJ case reports
2021

Venetoclax/decitabine for a pediatric patient with chronic myelomonocytic leukemia.

Pediatric blood & cancer
2020

Many signs, one mutation: Early onset of de novo GATA2 deficiency syndrome. A case report.

Clinical case reports
2020

Secondary pulmonary alveolar proteinosis in GATA-2 deficiency (MonoMAC syndrome).

BMJ case reports
2020

Genotypes versus phenotypes: The potential paradigm shift in the diagnosis and management of pediatric neoplasms.

Pediatric investigation
2020

GATA2 Related Conditions and Predisposition to Pediatric Myelodysplastic Syndromes.

Cancers
2020

Germline predisposition in myeloid neoplasms: Unique genetic and clinical features of GATA2 deficiency and SAMD9/SAMD9L syndromes.

Best practice & research. Clinical haematology
2021

Possible mechanisms by which silkworm faeces extract ameliorates adenine-induced renal anaemia in rats.

Journal of ethnopharmacology
2020

Human GATA2 mutations and hematologic disease: how many paths to pathogenesis?

Blood advances
2022

Recalcitrant Herpes Zoster Ophthalmicus in a Patient Discovered to Have Underlying Functional Natural Killer Cell Deficiency.

Ocular immunology and inflammation
2020

Human NK cells prime inflammatory DC precursors to induce Tc17 differentiation.

Blood advances
2020

Natural gene therapy in hematopoietic disorders: GATA too.

Blood
2020

Allogeneic hematopoietic cell transplantation in the management of GATA2 deficiency and pulmonary alveolar proteinosis.

Clinical immunology (Orlando, Fla.)
2020

GATA2 deficiency in a young man with lymphoedema.

British journal of haematology
2020

Hereditary Predisposition to Hematopoietic Neoplasms: When Bloodline Matters for Blood Cancers.

Mayo Clinic proceedings
2020

GATA2 functions in adrenal chromaffin cells.

Genes to cells : devoted to molecular & cellular mechanisms
2020

Humoral deficiency in a novel GATA2 mutation: A new clinical presentation successfully treated with hematopoietic stem cell transplantation.

Pediatric blood & cancer
2020

Sequencing of RNA in single cells reveals a distinct transcriptome signature of hematopoiesis in GATA2 deficiency.

Blood advances
2020

Somatic genetic rescue in hematopoietic cells in GATA2 deficiency.

Blood
2020

Synonymous GATA2 mutations result in selective loss of mutated RNA and are common in patients with GATA2 deficiency.

Leukemia
2022

Familial Emberger Syndrome With Autoimmunity, Hyper-Immunoglobulin E and Lymphatic Impairment Caused by a Novel GATA2 Mutation.

Hematology/oncology and stem cell therapy
2020

A Panoply of Rheumatological Manifestations in Patients with GATA2 Deficiency.

Scientific reports
2021

Breaking the spatial constraint between neighboring zinc fingers: a new germline mutation in GATA2 deficiency syndrome.

Leukemia
2020

GATA2 +9.5 enhancer: from principles of hematopoiesis to genetic diagnosis in precision medicine.

Current opinion in hematology
2020

Landscape of Tumor Suppressor Mutations in Acute Myeloid Leukemia.

Journal of clinical medicine
2020

Natural killer cells get under your skin.

Science translational medicine
2020

Blood natural killer cell deficiency reveals an immunotherapy strategy for atopic dermatitis.

Science translational medicine

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Síndrome de surdez-linfedema-leucemia.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Síndrome de surdez-linfedema-leucemia

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. GATA2 deficiency exacerbates chronic liver injury via disrupting hepatocyte death-regeneration balance: Clinical, histopathological, and molecular evidence.
    World journal of stem cells· 2026· PMID 41808888mais citado
  2. IL-1β as Target to Induce Synthetic Lethality in KRAS Mutant Biliary Tract Cancer.
    Clinical and molecular hepatology· 2026· PMID 41715263mais citado
  3. Clinical relevance of mosaic variants detected by exome sequencing.
    The Journal of allergy and clinical immunology· 2026· PMID 41724404mais citado
  4. GATA2 controls alveolar macrophage inflammatory gene expression and metabolic function.
    JCI insight· 2026· PMID 41712459mais citado
  5. A CRISPR-Based Humanized Model Reveals Cooperative Role of STAG2 Loss in Familial GATA2-Deficient MDS Progression.
    bioRxiv : the preprint server for biology· 2026· PMID 41676615mais citado
  6. Emberger syndrome-primary lymphedema with myelodysplasia: report of seven new cases.
    Am J Med Genet A· 2010· PMID 20803646recente
  7. [Deaf-mutism, lymphedema of the lower limbs and hematological abnormalities (acute leukemia, cytopenia) with autosomal dominant transmission].
    J Genet Hum· 1979· PMID 295075recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:3226(Orphanet)
  2. OMIM OMIM:614038(OMIM)
  3. MONDO:0013540(MONDO)
  4. GARD:13030(GARD (NIH))
  5. Variantes catalogadas(ClinVar)
  6. Busca completa no PubMed(PubMed)
  7. Q55610804(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Síndrome de surdez-linfedema-leucemia
Compêndio · Raras BR

Síndrome de surdez-linfedema-leucemia

ORPHA:3226 · MONDO:0013540
CID-10
D46.7 · Outras síndromes mielodisplásicas
CID-11
MedGen
UMLS
C3279664
Repurposing
19 candidatos
azosemideelectrolyte reabsorption inhibitor
benzthiazidecarbonic anhydrase inhibitor
bumetanidesolute carrier family member inhibitor
+16 outros
Wikidata
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades